Sodium Bicarbonate in 5% Dextrose Injection — Class II drug recall D-0768-2021
Terminated recall by SterRx, LLC, reported 2021-09-01, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0768-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SterRx, LLC, Plattsburgh, NY, United States |
| Recall initiated | 2021-08-10 |
| Classified | 2021-08-25 |
| Reported by FDA | 2021-09-01 |
| Terminated | 2022-05-19 |
| Distributed | Nationwide (US) |
| Quantity | 3,378 bags |
| Reason classes | sterility |
| Expiration dates | 2022-03-08, 2022-03-16 |
Product
Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0768-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.